HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Binbin Wang Selected Research

trans-activation responsive RNA-binding protein

1/2022The Interaction of Influenza A NS1 and Cellular TRBP Protein Modulates the Function of RNA Interference Machinery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Binbin Wang Research Topics

Disease

21Neoplasms (Cancer)
01/2022 - 01/2016
19Alzheimer Disease (Alzheimer's Disease)
10/2021 - 10/2004
8Infections
01/2022 - 12/2010
8Primary Ovarian Insufficiency
02/2018 - 01/2010
7Cataract (Cataracts)
09/2012 - 04/2010
6Gout
01/2020 - 04/2011
4Inflammation (Inflammations)
11/2022 - 11/2020
4Ischemic Stroke
06/2018 - 08/2010
4Spontaneous Abortion (Miscarriage)
06/2014 - 09/2010
3Virus Diseases (Viral Diseases)
01/2022 - 02/2021
3COVID-19
01/2022 - 12/2020
3Hyperalgesia
11/2019 - 01/2018
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2011 - 08/2009
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
2Triple Negative Breast Neoplasms
10/2021 - 07/2020
2Spinal Cord Injuries (Spinal Cord Injury)
04/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2018
2Zika Virus Infection
12/2020 - 01/2020
2Breast Neoplasms (Breast Cancer)
07/2020 - 01/2016
2Stomach Neoplasms (Stomach Cancer)
12/2019 - 08/2013
2Neuralgia (Stump Neuralgia)
11/2019 - 05/2019
2Hypoxia (Hypoxemia)
01/2019 - 12/2018
2Stroke (Strokes)
12/2017 - 05/2014
2Wounds and Injuries (Trauma)
12/2017 - 12/2014
2Poisoning
03/2016 - 07/2015
2Ventricular Heart Septal Defects (Ventricular Septal Defect)
12/2015 - 01/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
09/2011 - 08/2010
2Congenital Heart Defects (Congenital Heart Defect)
02/2011 - 01/2011
1Exanthema (Rash)
01/2022
1Tics (Tic)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Human Influenza (Influenza)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Pneumonia (Pneumonitis)
11/2021
1Glioblastoma (Glioblastoma Multiforme)
09/2021
1Papillary Thyroid Microcarcinoma
06/2021

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
7RNA (Ribonucleic Acid)IBA
01/2022 - 01/2016
5Small Interfering RNA (siRNA)IBA
01/2022 - 01/2018
5VaccinesIBA
01/2022 - 01/2017
5Transcription Factors (Transcription Factor)IBA
10/2021 - 02/2011
5Biological ProductsIBA
09/2021 - 01/2005
4Long Noncoding RNAIBA
01/2021 - 12/2019
4NucleotidesIBA
08/2020 - 04/2010
4Uric Acid (Urate)IBA
07/2012 - 04/2011
3Messenger RNA (mRNA)IBA
01/2022 - 10/2017
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 06/2014
3Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2014
3Amyloid (Amyloid Fibrils)IBA
10/2021 - 01/2005
3MicroRNAs (MicroRNA)IBA
09/2021 - 01/2016
3CytokinesIBA
11/2020 - 01/2018
3Bone Morphogenetic Protein 15IBA
02/2018 - 01/2010
3Apolipoproteins E (ApoE)IBA
01/2018 - 01/2006
3CholesterolIBA
04/2011 - 10/2004
3ConnexinsIBA
02/2011 - 04/2010
3ApolipoproteinsIBA
01/2010 - 01/2006
2Immunoglobulin A (IgA)IBA
11/2022 - 11/2021
2Small Untranslated RNAIBA
01/2022 - 12/2021
2AntibodiesIBA
01/2022 - 08/2020
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2021 - 01/2020
2Circular RNAIBA
09/2021 - 09/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 01/2019
2PolyphenolsIBA
11/2020 - 02/2019
2Peptides (Polypeptides)IBA
01/2020 - 01/2005
2Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2019 - 01/2016
2Retinaldehyde (Retinal)IBA
12/2018 - 08/2018
2Pharmaceutical PreparationsIBA
01/2018 - 11/2017
2Glutathione (Reduced Glutathione)IBA
11/2017 - 03/2014
2PesticidesIBA
03/2016 - 07/2015
2phoximIBA
03/2016 - 07/2015
2Mitogen-Activated Protein KinasesIBA
06/2014 - 05/2014
2Estrogen ReceptorsIBA
06/2014 - 09/2012
2Carrier Proteins (Binding Protein)IBA
08/2012 - 08/2010
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2011 - 01/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2010 - 07/2008
2Cholesterol 24-Hydroxylase (CYP46A1)IBA
01/2010 - 10/2004
2FluorineIBA
04/2007 - 10/2004
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1SolutionsIBA
01/2022
1trans-activation responsive RNA-binding proteinIBA
01/2022
1Gefitinib (Iressa)FDA Link
01/2022
1olaparibIBA
01/2022
1Minocycline (Cyclops)FDA LinkGeneric
01/2022
1icotinibIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Neutralizing AntibodiesIBA
11/2021
1SiliconIBA
11/2021
1aluminum sulfate (alum)IBA
11/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1Chemotactic FactorsIBA
10/2021
1ChemokinesIBA
10/2021
1EphA1 Receptor (Eph Receptor)IBA
09/2021
1Untranslated RNA (Noncoding RNA)IBA
09/2021
1Transfer RNA (tRNA)IBA
09/2021

Therapy/Procedure

4Therapeutics
01/2022 - 06/2017
4Immunotherapy
10/2021 - 11/2017
4Spinal Injections
11/2019 - 01/2018
2Aftercare (After-Treatment)
01/2020 - 12/2014
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 01/2018